Turning Point Therapeutics OverviewTurning Point Therapeutics Other Income Expense Net
Other Income/Expense Net for TPTX.
Quarterly Other Income/Expense
$1.28M
↑ 232.29% YoY
As of Jun 30, 2022
Annual Other Income/Expense (TTM)
$2.29M
↓ 1.72% YoY
Trailing 12 months ending Jun 30, 2022